Alnylam Pharmaceuticals
ALNY
#606
Rank
A$51.93 B
Marketcap
$402.69
Share price
-1.49%
Change (1 day)
55.72%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company